Pancreatic cancer is a devastating therapy-resistant disease. By locally delivering a large amount of drugs directly into a tumor mass via devices, we are able to mechanically contain tumor progression. This project offers the best of systemic and palliative care: dramatically enhancing chemotherapeutic efficacy while improving quality of life. The team is focused on designing innovative technologies to alleviate adverse effects, and potentially convert more tumors from inoperable to operable (Renewal from 2014 grant round).
The technology from this project was spun out into a startup company, PanTher Therapeutics.
Laura presented their research findings at a TED talk in Februray 2016. Watch below.
In the News: